Salim Yalcin Inan
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 17, 2025
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.Ebru Guclu, Salim Yalcin Inan, Canan Eroglu Gunes
|Oct 05, 2023
P/Q type (Cav2.1) Calcium Channel Blocker ω-Agatoxin IVA Alters Cleaved Caspase-3 and BDNF Expressions in the Rat Brain and Suppresses Seizure Activity.Salim Yalcin Inan, Sendegul Yildirim, Gamze Tanriover
|Sep 08, 2022
The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways.Ebru Guclu, Salim Yalcin Inan, Hasibe Cingilli Vural
|Sep 13, 2021
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats.Burak Cem Soner, Eda Acikgoz, Salim Yalcin Inan
|Mar 22, 2016
Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.Salim Yalcin Inan, Burak Cem Soner, Ayse Saide Sahin
Pageof 1
Frequent Collaborators
1 joint publications
Burak Cem Soner
1 joint publications
Eda Acikgoz
1 joint publications
Sule Ayla
1 joint publications
Ayse Saide Sahin
1 joint publications
Gulperi Oktem
1 joint publications
Sendegul Yildirim
1 joint publications
Gamze Tanriover
1 joint publications
Barkin Ilhan
1 joint publications
Ebru Guclu
1 joint publications
Canan Eroglu Gunes
